MetaADEDB 2.0 @ LMMD
besifloxacin
(QFFGVLORLPOAEC-SNVBAGLBSA-N)
Structure
SMILES
N[C@@H]1CCCCN(C1)c1c(F)cc2c(c1Cl)n(cc(c2=O)C(=O)O)C1CC1
Type(s)
Approved
ATC code(s)
S01AE08
Molecular Formula:
C19H21ClFN3O3
Molecular Weight:
393.840
Log P:
3.9100
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
2
TPSA:
88.56
CAS Number(s):
141388-76-3
Synonym(s)
1.
besifloxacin
2.
7-((3R)-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
3.
7-(3-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
4.
BOL-303224-A
5.
besifloxacin hydrochloride
6.
besivance
External Link(s)
MeSHC522124
PubChem Compound10178705
ChEBI135622
CHEMBLCHEMBL1201760
DrugBankDB06771
DrugCentral4111
KEGGdr:D08872
Therapeutic Target DatabaseD00TRV
ZINC3787097
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Long QT SyndromeFAERS: 1US FAERS
2OverdoseFAERS: 1US FAERS
3Eye irritationSIDER
4Eye painSIDER
5HeadacheSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.